FDA Asks for Recalls of Sanofi's Zantac and All Generic Versions
The agency says there is a risk that some of the heartburn pills may contain unacceptable levels of NDMA, a possible carcinogen.
Full Article
FDA Asks for Recalls of Sanofi's Zantac and All Generic Versions
Motley Fool
0 shares
1 views